USP43 and ovarian carcinoma: Current evidence is restricted to a solitary publication demonstrating USP43-mediated apoptotic regulation in ovarian cancer via the Wnt/β-catenin signaling axis [34], while its potential involvement in governing ferroptosis, necroptosis, and immunogenic cell death remains uncharted in oncological research.